Regulation of transcription with glucocorticoid receptor and other transcription factors
Project/Area Number |
11671102
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Endocrinology
|
Research Institution | Fujita Health University |
Principal Investigator |
OSHIMA Hisaji Fujita Health University School of Medicine, Internal Medicine, Assistant Professor, 医学部, 助教授 (90138008)
|
Co-Investigator(Kenkyū-buntansha) |
KATAYAMA Masao Fujita Health University School of Medicine, Intrenal Medicine, Associate Professor, 医学部, 講師 (00278285)
澤田 誠 藤田保健衛生大学, 総合医科学研究所, 教授 (10187297)
|
Project Period (FY) |
1999 – 2000
|
Project Status |
Completed (Fiscal Year 2000)
|
Budget Amount *help |
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2000: ¥1,800,000 (Direct Cost: ¥1,800,000)
Fiscal Year 1999: ¥1,700,000 (Direct Cost: ¥1,700,000)
|
Keywords | glucocorticoids / receptors / steroids / transcription |
Research Abstract |
Glucocorticoid receptor was a ligand-inducible transcription factor, and activates or inhibit transcription of target genes. We, in this project, have identified and clarified glucocorticoid modulatory elements binding proteins (GMEB) which works as a gene specific and tissue specific modulator of regulation of gene transcription by glucocorticoids. GMEBs are now identified as a heteroologomeric complex (GMEB-1 and GMEB-2) present in cytoplasma and nucleus in cells. GMEB-1 and GMEB-2 are 68KDa and 88KDa proteins respectively. Cloning of GMEB-1 and GMEB-2 cDAA shows that these proteins have unique primary protein sequences. We find also that GMEB functions as a transcription factor where they bind to DNA as a sequence specific manner. In vitro, GMEB binds to a palindromic sequence which is most preferentialy GCGA/CNNNG/TCGC.Biological activities of GMEB can vary in different tissues and also by a change in the growth conditions of cells. In addition, a splice variant of GMEB-1 was identified and sequenced. These findings can be a most hopeful evidence to undrestand a gene and tissue specific modulation of the glucocorticoid hormone actions and to develop more specific and powerful glucocorticoid therapies where less adverse effects are expected.
|
Report
(3 results)
Research Products
(2 results)
-
-
[Publications] Fukaya S, Oshima H, Kato K, Komatsu, Y, Matsumura H, Ishii K, Miyama H, Nagai T Tanaka I, Mizutani A, Katayama M, Yoshida S, Torikai K: "KL-6 as a novel marker for activities of interstitial pneumonia in connective tissue diseases."Rheumatol.Int.. 19 (6). 223-225 (2000)
Description
「研究成果報告書概要(欧文)」より
Related Report